Plexus Holdings PLC (AIM:POS) chief executive Ben van Bilderbeek said recent orders for its wellhead and sealing technology have marked a turning point for the group.
In particular, one order worth £5mln was the largest ever received by the business and validates the advantages of its POS-GRIP technology, he added.
Helium One Global Ltd (AIM:HE1, OTCQB:HLOGF) booked a loss of US$1.9mln in the six months to December 2022, broadly flat on the US$1.8mln loss booked in the comparable period a year earlier.
The company had net cash balance as at 31 December 2022 of US$13.7mln.
Anglo Asian Mining PLC (AIM:AAZ, OTC:AGXKF) confirmed that it has the potential to produce over 300,000 tonnes of copper from its Garadag porphyry deposit in Azerbaijan.
Anglo Asian acquired historic geological data from AzerGold CJSC relating to the Garadag deposit, which is hosted within the Garadag contract area and located north of the company's Gedabek and Xarxar contract areas.
Bradda Head Lithium Limited (AIM:BHL, OTCQB:BHLIF, TSX-V:BHLI) has returned further significant intercepts of high grade lithium-bearing minerals at multiple locations from the second set of assay results from its maiden diamond core drilling programme at the San Domingo pegmatite district in Arizona.
This is a continuation of the first extensive drilling campaign undertaken at San Domingo since the 1950s, but is the maiden programme under Bradda Head.
ImmuPharma PLC (AIM:IMM, OTC:IMMPF) said its partner Avion Pharmaceuticals has submitted the phase II/III clinical protocol for Lupuzor to the US Food and Drug Administration (FDA).
This promising treatment is for patients with systemic lupus erythematosus (SLE/Lupus). The new trial design addresses the US regulator's guidance on exploring higher dose levels and incorporates insights from the pharmacokinetic (PK) study completed last year.
Allergy Therapeutics PLC (AIM:AGY, OTC:AGYTF), the commercial-stage biotech company, has started administering its groundbreaking short-course peanut allergy vaccine candidate, VLP Peanut, to phase I PROTECT trial patients.
The first-of-its-kind study aims to evaluate the safety, tolerability and preliminary efficacy of VLP Peanut in both healthy and peanut-allergic adults.
CentralNic Group PLC (AIM:CNIC) has published its annual accounts and confirmed all key figures remain unchanged from the statement on 27 February 2023.
The global internet platform saw its full-year 2022 revenue increase by 77% to US$728.2mln (FY2021: US$410.5mln), with organic revenue growth of 60% (FY2021: 39%).
With the intention of building on its strong lithium portfolio in Austria at the heart of Europe’s burgeoning electric vehicle industry and decarbonisation drive, European Lithium Ltd (ASX:EUR, OTCQB:EULIF) has signed an agreement to acquire three projects in the resource-rich Styria mining district.
A binding Heads of Agreement (HoA) with 2743718 Ontario Inc., a subsidiary of Richmond Minerals Inc, covers 100% of the rights, title and interest in the Bretstein-Lachtal Project, Klementkogel Project and Wildbachgraben Project.
Ora Banda Mining Ltd (ASX:OBM) is raising up to A$30 million in a well-supported two-tranche placement of new fully paid ordinary shares.
In a strong show of support, directors committed to an A$1.2 million total investment, subject to shareholder approval, while major shareholder Hawke’s Point committed to an A$8 million investment which is subject to shareholder approval.